Showing results (31-40 of 3,800) with videos related to
Sort By:
Pageof 380
Clinical Biochemistry|October 19, 2006
Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal diseaseKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecCytokine|October 31, 2006
Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patientsKrystyna Pawlak, Dariusz Pawlak, Michal MyśliwiecPolskie Archiwum Medycyny Wewnetrznej|July 5, 2014
Effect of diabetes and oxidative stress on plasma CCL23 levels in patients with severe chronic kidney diseaseKrystyna Pawlak, Michał Myśliwiec, Dariusz PawlakThrombosis Research|September 18, 2007
Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecClinical Biochemistry|June 21, 2005
Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal diseaseKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecLife Sciences|January 9, 2013
Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?Krystyna Pawlak, Michal Mysliwiec, Dariusz PawlakDiabetes Research and Clinical Practice|October 2, 2012
The alteration in Cu/Zn superoxide dismutase and adhesion molecules concentrations in diabetic patients with chronic kidney disease: the effect of dialysis treatmentKrystyna Pawlak, Michal Mysliwiec, Dariusz PawlakPrzeglad Lekarski|April 27, 2005
[Hypoxia involvement in erythropoiesis regulation--a new insight]Sebastian Pawlak, Dariusz Pawlak, Włodzimierz BuczkoThrombosis Research|June 21, 2005
Oxidative stress effects fibrinolytic system in dialysis uraemic patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecAmerican Journal of Nephrology|March 27, 2007
Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecPageof 380